Secondary analyses to assess the profound effects of empagliflozin on endothelial function in patients with type 2 diabetes and established cardiovascular diseases: The placebo‐controlled double‐blind randomized effect of empagliflozin on endothelial function in cardiovascular high risk diabetes mellitus: Multi‐center placebo‐controlled double‐blind randomized trial
Saved in:
| Title: | Secondary analyses to assess the profound effects of empagliflozin on endothelial function in patients with type 2 diabetes and established cardiovascular diseases: The placebo‐controlled double‐blind randomized effect of empagliflozin on endothelial function in cardiovascular high risk diabetes mellitus: Multi‐center placebo‐controlled double‐blind randomized trial |
|---|---|
| Authors: | Tanaka, Atsushi1 (AUTHOR) tanakaa2@cc.saga-u.ac.jp, Shimabukuro, Michio2 (AUTHOR), Machii, Noritaka2 (AUTHOR), Teragawa, Hiroki3 (AUTHOR), Okada, Yosuke4 (AUTHOR), Shima, Kosuke R.5 (AUTHOR), Takamura, Toshinari5 (AUTHOR), Taguchi, Isao6 (AUTHOR), Hisauchi, Itaru6 (AUTHOR), Toyoda, Shigeru7 (AUTHOR), Matsuzawa, Yasushi8 (AUTHOR), Tomiyama, Hirofumi9 (AUTHOR), Yamaoka‐Tojo, Minako10 (AUTHOR), Ueda, Shinichiro11 (AUTHOR), Higashi, Yukihito12 (AUTHOR), Node, Koichi1 (AUTHOR) |
| Source: | Journal of Diabetes Investigation. Nov2020, Vol. 11 Issue 6, p1551-1563. 13p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
